Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: A cohort study

Journal of Dental Research

Volumn 93, Issue 11, 2014, Pages 1054-1061

  Wu, X ^a   Al Abedalla, K ^a   Rastikerdar, E ^a   Abi Nader, S ^a   Daniel, N G ^b   Nicolau, B ^a   Tamimi, F ^a  

^a MCGILL UNIVERSITY   (Canada)

^b East Coast Oral Surgery   (Canada)

Author keywords

bone remodeling; dental implants; epidemiology; medical devices; osseointergration; risk factors

Indexed keywords

DENTAL MATERIAL; SEROTONIN UPTAKE INHIBITOR; TITANIUM; TOOTH IMPLANT;

ADOLESCENT; ADULT; AGED; BONE REGENERATION; CHEMISTRY; COHORT ANALYSIS; COMPARATIVE STUDY; DENTAL SURGERY; DRUG EFFECTS; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; TOOTH IMPLANT; TOOTH PROSTHESIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DENTAL IMPLANTS; DENTAL MATERIALS; DENTAL PROSTHESIS DESIGN; DENTAL RESTORATION FAILURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OSSEOINTEGRATION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SMOKING; TITANIUM; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84910067595     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034514549378     Document Type: Article

References (32)

1. Albrektsson T, Brånemark P-I, Hansson H-A, Lindström J. Osseointegrated titanium implants: requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop. 1981 ; 52: 155-170
2. Alsaadi G, Quirynen M, Komárek A, Van Steenberghe D. Impact of local and systemic factors on the incidence of late oral implant loss. Clin Oral Implants Res. 2008 ; 19: 670-676
3. Battaglino R, Fu J, Späte U, Ersoy U, Joe M, Sedaghat L, et al. Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res. 2004 ; 19: 1420-1431
4. Carlsson L, Röstlund T, Albrektsson B, Albrektsson T, Brånemark PI. Osseointegration of titanium implants. Acta Orthop. 1986 ; 57: 285-289
5. Charalampakis G, Leonhardt Å, Rabe P, Dahlén G. Clinical and microbiological characteristics of peri-implantitis cases: a retrospective multicentre study. Clin Oral Implants Res. 2012 ; 23: 1045-1054
6. Davarpanah M, Martinez H, Tecucianu JF, Celletti R, Lazzara R. Small diameter implants: indications and contraindications. J Esthet Restor Dent. 2000 ; 12: 186-194
7. Del Valle V, Faulkner G, Wolfaardt J, Rangert B, Tan HK. Mechanical evaluation of craniofacial osseointegration retention systems. Int J Oral Maxillofac Implants. 1995 ; 10: 491-498
8. Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM, et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med. 2007 ; 167: 1240-1245
9. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants (II): etiopathogenesis. Eur J Oral Sci. 1998 ; 106: 721-764
10. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002 ; 84: 454-464
11. Gustafsson B, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum H, et al. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem. 2006 ; 98: 139-151
12. Kemp F. Applied multiple regression/correlation analysis for the behavioral sciences. J R Stat Soc Series B Stat. 2003 ; 52: 691
13. Krall EA, Dawson-Hughes B. Smoking and bone loss among postmenopausal women. J Bone Miner Res. 1991 ; 6: 331-338
14. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008 ; 455: 894-902
15. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1998 ; 351: 1303-1307
16. Misch CE, Perel ML, Wang HL, Sammartino G, Galindo-Moreno P, Trisi P, et al. Implant success, survival, and failure: the International Congress of Oral Implantologists (ICOI) pisa consensus conference. Implant Dent. 2008 ; 17: 5-15
17. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997 ; 349: 1436-1442
18. Pjetursson BE, Thoma D, Jung R, Zwahlen M, Zembic A. A systematic review of the survival and complication rates of implant-supported fixed dental prostheses (FDPs) after a mean observation period of at least 5 years. Clin Oral Implants Res. 2012 ; 23: 22-38
19. Porter JA, von Fraunhofer JA. Success or failure of dental implants? A literature review with treatment considerations. Gen Dent. 2004 ; 53: 423-432
20. Riebel GD, Boden SD, Whitesides TE, Hutton WC. The effect of nicotine on incorporation of cancellous bone graft in an animal model. Spine (Phila Pa 1976). 1995 ; 20: 2198-2202
21. Schep N, Heintjes R, Martens E, van Dortmont L, Van Vugt A. Retrospective analysis of factors influencing the operative result after percutaneous osteosynthesis of intracapsular femoral neck fractures. Injury. 2004 ; 35: 1003-1009
22. Sibilia V, Pagani F, Dieci E, Mrak E, Marchese M, Zarattini G, et al. Dietary tryptophan manipulation reveals a central role for serotonin in the anabolic response of appendicular skeleton to physical activity in rats. Endocrine. 2013 ; 44: 790-802
23. Stephenson J, Chadwick B, Playle R, Treasure E. Modelling childhood caries using parametric competing risks survival analysis methods for clustered data. Caries Res. 2010 ; 44: 69-80
24. Tamimi I, Ojea T, Sanchez-Siles JM, Rojas F, Martin I, Gormaz I, et al. Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: a case-control study. J Bone Miner Res. 2012 ; 27: 1518-1527
25. Tonetti MS, Schmid J. Pathogenesis of implant failures. Periodontol. 1994 2000 ;: 4 127-138
26. Tonetti MS, Pini-Prato G, Cortellini P. Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. J Clin Periodontol. 1995 ; 22: 229-234
27. Tsapakis E, Gamie Z, Tran G, Adshead S, Lampard A, Mantalaris A, et al. The adverse skeletal effects of selective serotonin reuptake inhibitors. Eur Psychiatry. 2012 ; 27: 156-169
28. Verdel BM, Souverein PC, Egberts TC, Van Staa TP, Leufkens HG, de Vries F. Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone. 2010 ; 47: 604-609
29. Wong M, Eulenberger J, Schenk R, Hunziker E. Effect of surface topology on the osseointegration of implant materials in trabecular bone. J Biomed Mater Res. 1995 ; 29: 1567-1575
30. Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 2008 ; 135: 825-837
31. Yamazaki M, Kanzaki S, Tominaga K, Miyamoto I, Yamauchi K, Fukuda M, et al. Evaluation of secondary bone grafting of the alveolar cleft in adult cleft lip and palate patients. J Oral Maxillofac Surg Med Pathol. 2012 ; 24: 86-89
32. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986 ; 42: 121-130